SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-09-000125
Filing Date
2009-01-26
Accepted
2009-01-26 09:11:36
Documents
3
Period of Report
2009-01-22
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K w72437e8vk.htm 8-K 19649
2 EX-99.1 w72437exv99w1.htm EX-99.1 12443
3 GRAPHIC w72437w7243701.gif GRAPHIC 4681
  Complete submission text file 0000950133-09-000125.txt   40290
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-09601 | Film No.: 09544152
SIC: 2834 Pharmaceutical Preparations